Shah H A, Piris J, Finlayson N D
Gastrointestinal and Liver Service, Royal Infirmary, Edinburgh University Medical School, UK.
Eur J Gastroenterol Hepatol. 1995 Mar;7(3):283-6.
To describe a patient with pulmonary and portal hypertension and to review the pathogenesis and management of this condition.
A 22-year-old woman with portal hypertension and liver cirrhosis who later developed pulmonary hypertension.
The patient received antibiotic therapy and underwent a splenectomy and proximal splenorenal shunt for portal hypertension. She later received hydralazine, digoxin and warfarin for pulmonary hypertension.
After undergoing a splenorenal shunt the patient made a good recovery. However, she later developed pulmonary hypertension and died after undergoing a hysterectomy and a bilateral salpingo-oophorectomy.
The concomitant development of portal and pulmonary hypertension in the same patient has a poor prognosis. The treatment available for patients with these conditions is unsatisfactory and most patients eventually die as a result of cardiovascular disease. Cardiopulmonary and liver transplantation should be considered in suitable patients.
描述一名患有肺动脉高压和门脉高压的患者,并回顾该病症的发病机制及治疗方法。
一名22岁女性,患有门脉高压和肝硬化,后来发展为肺动脉高压。
患者接受了抗生素治疗,并因门脉高压接受了脾切除术和近端脾肾分流术。她后来因肺动脉高压接受了肼屈嗪、地高辛和华法林治疗。
接受脾肾分流术后,患者恢复良好。然而,她后来发展为肺动脉高压,并在接受子宫切除术和双侧输卵管卵巢切除术后死亡。
同一患者同时发生门脉高压和肺动脉高压,预后较差。针对这些病症患者的现有治疗方法并不令人满意,大多数患者最终死于心血管疾病。对于合适的患者应考虑进行心肺和肝移植。